“ Welcome to OpenDELClub ” HitGen OpenDELClub A platform for researchers and professionals interested in DNA-encoded library (DEL) technology and drug discovery, providing a space for knowledge exchange, innovation, and partnership. Learn More
News 4 July 2025 ESG | HitGen Releases Its Inaugural Sustainability Report CHENGDU, China, July 4, 2025 – Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced the release of its inaugural sustainability report, aiming to present the company's philosophies and policies in environmental, social, and governance ("ESG") areas, as well as its sustainability practices and performance in the year of 2024, systematically addressing stakeholders' concerns. Dr. Jin Li, Chairman of the Board and CEO of HitGen Inc., commented: "It is my great pleasure to share with you HitGen's inaugural Sustainability Report. As an enterprise at the forefront of drug discovery research, HitGen aspires to advance innovative drug discovery for the healthcare industry. We are committed to original innovation of drug discovery, continuously delivering new molecular entities to the industry, and contributing to improved human health. In 2024, while continuing to enhance our competitiveness in biopharmaceutical R&D services, we systematically integrated sustainability concepts throughout our operational processes, striving to achieve synergistic development in governance efficiency, low-carbon transmission, talent development, and community well-being." Sustainable Corporate GovernanceA robust governance framework and capabilities form the solid foundation for sustainable corporate development. HitGen continuously enhances its governance structure to ensure transparent and scientific decision-making. Adhering to compliance and ethical standards as the baseline, we operate with integrity to establish industry benchmarks. We are committed to building a comprehensive risk management system, driving long-term and stable corporate growth, and creating sustainable value for all stakeholders. Responsible Value ChainHitGen advances sustainable development across its entire value chain from supply, operations to client engagement by establishing sustainable supply chain system, industry-academia-research collaborative innovation networks, full-cycle quality control mechanisms, and robust data security safeguards, for the purpose of continuously building a resilient and responsible value ecosystem to fulfill its long-term commitment to human health. Harmonious Internal and External EcosystemHitGen takes social responsibility as its fundamental duty, demonstrating support through safeguarding employee rights and interests, creating an inclusive atmosphere with diversity and equality, empowering personal growth through training and development programs, protecting employee health and safety, and actively engaging in community contributions – all these actions exemplify the Company’s commitment to society. Eco-Conscious Environmental ManagementAdhering to the "Eco-Conscious, Planet-Responsible" philosophy, HitGen is dedicated in minimizing adverse impacts on the environment during R&D and operations, conserving natural resources, reducing greenhouse gas emissions, and protecting biodiversity and clean water sources. Dr. Jin Li said, "Guided by our value-creation-driven sustainability vision, we firmly believe our fundamental mission is to create value for society, value for development, and value for the future – thereby propelling technological innovation and business expansion. On this journey, we will persistently leverage market needs as our compass and technological breakthroughs as our engine, continuously optimizing our innovative drug R&D service system to build an ecosystem of positive reciprocity where patients benefit, the industry advances, employees grow, and all stakeholders achieve shared success." For more information on HitGen's Sustainability Report, please visit https://www.hitgen.com/en/sustainability.html Learn More Activity 10 June 2025 See you in Boston! HitGen to attend 2025 BIO International Convention From June 16th to 19th (US time), the 2025 BIO International Convention will take place at the Boston Convention & Exhibition Center in Massachusetts, USA. As the largest and most comprehensive event for biotechnology, the BIO International Convention represents the full ecosystem of biotech with 20,000 industry leaders from across the globe. HitGen Inc. looks forward to meeting you at Booth 1851. We also encourage scheduling meetings in advance through the BIO Partnering™ system to explore collaboration opportunities. Learn More
OpenDEL™ Kit Starting Your Journey to Access the Vast Chemical Space The Kit57 Libraries~3.8Bn compounds10 DEL samplesTo AccessFully enumerated moleculesBuilding Block StructuresDNA Codon SequencesScaffolds InformationNo Structure Disclosure FeeNo Structure Disclosure Fee
OpenDEL™ Screening OpenDEL™ screening is carried out by our team of experienced professionals, proficient in handling over 50 different target types including protein-protein interactions, kinases, enzymes, transcription factors, and RNA targets. Our team typically completes the screening experiments within 1-2 weeks. For more information and to explore detailed stories about our featured target types, click on the images below. We plan to release similar articles for other target classes in the future.
OpenDEL™ Sequencing HitGen offers high-quality sequencing services powered by two Illumina platforms (NextSeq2000 and NovaSeq6000) and one MGI platform (MGISEQ-2000), supported by 8 versatile flow cell types. Our flexible solutions cover a wide range of sequencing capacities, from 400M to 10,000M reads, tailored to your specific needs. With an average Q30 score exceeding 92% and a turnaround time of under two days, we deliver both speed and reliability for your research. In addition to DNA-encoded library (DEL) sequencing, we also provide multi-omics sequencing and data analysis services.
OpenDEL™ Hit Proposal Analyzing DEL selection data and choosing the right compounds for follow-up necessitates multidisciplinary expertise encompassing biology, computational science, and chemistry. This includes a deep understanding of the experimental design and mechanisms of action (MOAs) in biology, data processing and analysis in computational science, and aspects of both synthetic and DEL chemistry
OpenDEL™ Off-DNA Synthesis Our traditional synthesis service excels at recreating complex chemical structures derived from various DELs. We offer diverse options, including traditional chemistry synthesis service and high-throughput synthesis service. A. Traditional Chemical Synthesis @ HitGen B. High Throughput Chemical Synthesis @ HitGen‘s